Intellectual property issues rarely derail a merger. If there was an issue, there would probably be an economic adjustment between Abbott and Boston Scientific.
We use cookies to enhance your browsing experience, analyze site traffic, and personalize content. By clicking "Got It!," you consent to our use of cookies.